Provided by Tiger Trade Technology Pte. Ltd.

Kenvue Inc

17.80
+0.04500.25%
Volume:51.05M
Turnover:909.75M
Market Cap:34.10B
PE:20.94
High:17.92
Open:17.73
Low:17.72
Close:17.75
52wk High:20.13
52wk Low:14.02
Shares:1.92B
Float Shares:1.89B
Volume Ratio:2.58
T/O Rate:2.70%
Dividend:0.83
Dividend Rate:4.66%
EPS(TTM):0.8500
EPS(LYR):0.7600
ROE:15.58%
ROA:6.99%
PB:3.23
PE(LYR):23.41

Loading ...

Earning Preview: Kenvue Inc this quarter’s revenue is expected to increase by 2.94%, and institutional views are neutral

Earnings Agent
·
Jul 31

Kenvue Inc. Stock Falls Thursday, Underperforms Market

Dow Jones
·
Jul 31

Drugmakers, Retailers Must Face 'maximum Strength' Claim in Decongestant False Ad Litigation in US

Reuters
·
Jul 31

NYSE Order Imbalance 2211216.0 Shares on Buy Side

THOMSON REUTERS
·
Jul 30

Kenvue Increases Quarterly Dividend to $0.21 from $0.2075 a Share; Payable Aug. 26 to Holders of Record Aug. 12

MT Newswires Live
·
Jul 29

Kenvue Maintain Royal Dividend Status with 1.2% Increase

Dow Jones
·
Jul 29

Kenvue Raises Quarterly Dividend to $0.21 a Share

Reuters
·
Jul 29

Kenvue - Declares Qtrly Dividend of $0.21 Per Share, up 1.2% from Prior Dividend

THOMSON REUTERS
·
Jul 29

Kenvue Increases Quarterly Cash Dividend

THOMSON REUTERS
·
Jul 29

Kenvue Inc. Stock Rises Monday, Outperforms Market

Dow Jones
·
Jul 28

Kenvue (KVUE) Gains FDA Backing As Valuation Questions Return

Simply Wall St.
·
Jul 26

Kenvue Says FDA Has Granted Tylenol Three-year Exclusivity for New OTC Formulation

Reuters
·
Jul 25

Kenvue - FDA Grants Tylenol Three-year Exclusivity for New Otc Formulation

THOMSON REUTERS
·
Jul 25

Kenvue - Tylenol with Naproxen to be Available Soon at Major U.S. Retailers

THOMSON REUTERS
·
Jul 25

FDA Approves Tylenol® with Naproxen, the First and Only Over-the-counter Fixed-dose Combination of Acetaminophen (650 Mg) and Naproxen Sodium (220 Mg)

THOMSON REUTERS
·
Jul 25

Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)?

Simply Wall St.
·
Jul 24

Kenvue's Tylenol With Naproxen Combination Tablet Gets FDA Approval for Pain Relief

MT Newswires Live
·
Jul 24

US FDA - Approves Tylenol with Naproxen, First Otc Acetaminophen/naproxen Combination for 12-hour Pain Relief

THOMSON REUTERS
·
Jul 24

Kenvue Inc. Stock Falls Thursday, Still Outperforms Market

Dow Jones
·
Jul 24

Kenvue to Announce Second Quarter 2026 Results on August 6, 2026

THOMSON REUTERS
·
Jul 23